Exenatide Reduces Urinary Transforming Growth Factor-β1 and Type IV Collagen Excretion in Patients with Type 2 Diabetes and Microalbuminuria | Zendy

Hong Zhang | Zendy; Xiangcheng Zhang | Zendy; Changjun Hu | Zendy; Weiping Lu | Zendy

Open Access

Exenatide Reduces Urinary Transforming Growth Factor-β<sub>1</sub> and Type IV Collagen Excretion in Patients with Type 2 Diabetes and Microalbuminuria

Author(s) -

Hong Zhang,

Xiangcheng Zhang,

Changjun Hu,

Weiping Lu

Publication year - 2012

Publication title -

kidney and blood pressure research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.806

H-Index - 51

eISSN - 1423-0143

pISSN - 1420-4096

DOI - 10.1159/000337929

Subject(s) - microalbuminuria , medicine , endocrinology , exenatide , type 2 diabetes , urinary system , excretion , glycated hemoglobin , albuminuria , urology , diabetes mellitus

It was reported that exenatide ameliorated renal injury in diabetic rats. The present study was carried out to evaluate the effect of exenatide on 24-hour urinary albumin, urinary transforming growth factor-β(1) (TGF-β(1)) and type IV collagen excretion in patients with type 2 diabetes and microalbuminuria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research